NASDAQ Composite ended the session with Amgen jumping 1.85% to $246.14 on Friday while nASDAQ Composite dropped 0.65% to $13,027.06.
Amgen today’s close was $246.14, 7.65% under its 52-week high of $264.97.
Amgen’s sales growth is 6.3% for the ongoing quarter and 3.2% for the next. The company’s growth estimates for the current quarter is a negative 6.3% and positive 1% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s last day, last week, and last month’s average volatility was 1.65%, 0.65%, and 0.25%, respectively.
Amgen’s last day, last week, and last month’s high and low average amplitude percentage was 3.31%, 2.05%, and 2.00%, respectively.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $246.14 at 16:11 EST, below its 52-week high of $264.97 and way above its 52-week low of $177.05.
Amgen’s Moving Average
Amgen’s value is above its 50-day moving average of $229.06 and above its 200-day moving average of $238.79.